<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08904121810338</udiDi>
    <basicUdiDi>B-08904121810338</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0024</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:11.753Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810321</udiDi>
    <basicUdiDi>B-08904121810321</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:09.410Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810314</udiDi>
    <basicUdiDi>B-08904121810314</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:05.770Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810307</udiDi>
    <basicUdiDi>B-08904121810307</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:03.341Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810291</udiDi>
    <basicUdiDi>B-08904121810291</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:16:02.144Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810284</udiDi>
    <basicUdiDi>B-08904121810284</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7519</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:59.732Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810277</udiDi>
    <basicUdiDi>B-08904121810277</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:56.130Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810260</udiDi>
    <basicUdiDi>B-08904121810260</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2519</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:53.744Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810253</udiDi>
    <basicUdiDi>B-08904121810253</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0019</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:52.550Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810246</udiDi>
    <basicUdiDi>B-08904121810246</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:50.124Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810239</udiDi>
    <basicUdiDi>B-08904121810239</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:46.521Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810222</udiDi>
    <basicUdiDi>B-08904121810222</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:44.116Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810215</udiDi>
    <basicUdiDi>B-08904121810215</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.0016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:42.918Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810208</udiDi>
    <basicUdiDi>B-08904121810208</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.7516</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:40.516Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810192</udiDi>
    <basicUdiDi>B-08904121810192</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.5016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:36.909Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810185</udiDi>
    <basicUdiDi>B-08904121810185</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.2516</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:34.503Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810178</udiDi>
    <basicUdiDi>B-08904121810178</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 2.0016</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:33.312Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810161</udiDi>
    <basicUdiDi>B-08904121810161</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.5013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:30.904Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810154</udiDi>
    <basicUdiDi>B-08904121810154</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 4.0013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:27.388Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904121810147</udiDi>
    <basicUdiDi>B-08904121810147</basicUdiDi>
    <tradeName>Treat Sirolimus Eluting Coronary Stent System</tradeName>
    <deviceName>Treat Sirolimus Eluting Coronary Stent System</deviceName>
    <manufacturerName>Purple MicroPort Cardiovascular Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000028173</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P070402010301</emdnCode>
    <emdnDescription>CORONARY DRUG ELUTING STENTS (DES) WITH POLYMERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CC2.1 3.5013</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-01T06:15:23.758Z</lastUpdated>
  </row>
</eudamedExport>